PRO DERMA, Institut für klinische Studien und innovative Dermatologie

Research at PRO DERMA evaluates topical therapies for scabies, aiming to improve cure rates and reduce treatment duration.

• Clinical efficacy of InfectoScab 5% cream after one or two applications
• Comparison of permethrin 10% cream regimens in different study arms
• Treatment success assessed at 14‑28 days post‑application

The trials support faster, safer management of this parasitic skin disease at the Duelmen site.

Studies at the institute focus on mild to moderate atopic dermatitis, testing a new corticosteroid ointment for better symptom control.

• Safety and efficacy of methylprednisolone aceponate 0.1% ointment
• Direct comparison with the approved Advantan® 0.1% ointment
• Evaluation of a vehicle‑only control to assess active‑ingredient benefit

Findings aim to expand therapeutic options for patients with inflammatory skin conditions.